Erwinaze® (aaraginase Erwinia chrysanthemi) is part of a chemotherapy program to treat patients who have acute lymphoblastic leukemia (ALL), a type of blood cancer affecting the white blood cells that help fight infection. Erwinaze is used in patients who have had an allergic reaction to a different type of asparaginase treatment.
As with other leading oncology brands, peer-to-peer communication serves as a very important mechanism for Jazz Pharmaceuticals to help inform and educate oncology healthcare professionals (HCPs) about the use of Erwinaze in their practices. However, it is critical for the KOL promotional speakers facilitating these programs to find creative and dynamic ways to engage with their peers beyond a traditional slide deck presentation.
Jazz Pharmaceuticals challenged Viscira to develop an innovative and informative tool for their Erwinaze promotional speakers to use in a peer-to-peer setting with target oncology HCPs to engage the audience and help facilitate discussion. The client wanted the tool to allow speakers to interact with their audiences in a dynamic way to promote collaboration and idea exchange during the sessions.
Click here to read full article in PDF format.